9083 Oral vinorelbine in elderly or unfit patients with metastatic NSCLC

2009 ◽  
Vol 7 (2) ◽  
pp. 530
Author(s):  
L. Stumbo ◽  
B. Gori ◽  
E. Del Signore ◽  
S. Quadrini ◽  
R. De Sanctis ◽  
...  
Keyword(s):  
Oral Vinorelbine ◽  
Metastatic Nsclc ◽  
Unfit Patients

4023 POSTER First-line Oral Vinorelbine for Elderly or Unfit Patients With Advanced/metastatic Non-small Cell Lung Cancer

2011 ◽  
Vol 47 ◽  
pp. S280
Author(s):  
G. Mansueto ◽  
F. Longo ◽  
L. Stumbo ◽  
L. De Filippis ◽  
E. Del Signore ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Oral Vinorelbine ◽  
Unfit Patients

scholarly journals Metronomic Oral Vinorelbine: An Alternative Schedule in Elderly and Patients PS2 With Local/Advanced and Metastatic NSCLC Not Oncogene-addicted

In Vivo ◽  
2020 ◽  
Vol 34 (5) ◽  
pp. 2687-2691
Author(s):  
DAVID ROSSI ◽  
PAOLO LIPPE ◽  
MARCO BRUNO LUIGI ROCCHI ◽  
DONATELLA SARTI ◽  
VINCENZO CATALANO ◽  
...  
Keyword(s):  
Oral Vinorelbine ◽  
Metastatic Nsclc ◽  
Alternative Schedule ◽  
Local Advanced

scholarly journals 1294P RELAY, erlotinib plus ramucirumab or placebo in untreated EGFR-mutated metastatic NSCLC: Outcomes by EGFR mutation type

2020 ◽  
Vol 31 ◽  
pp. S838 ◽  
Author(s):  
K. Nakagawa ◽  
E. Nadal ◽  
E.B. Garon ◽  
M. Nishio ◽  
T. Seto ◽  
...  
Keyword(s):  
Egfr Mutation ◽  
Metastatic Nsclc ◽  
Egfr Mutated ◽  
Mutation Type
Sign in / Sign up

Export Citation Format

Share Document